Companies announce collaboration to develop the first implanted, whole-brain neural interface Powered by Butterfly’s Ultrasound-on-Chip™ technology.
Series B led by Double Point Ventures with major support from Viking Global Investors as well as other new and existing investors - - A combined $27.1 million Series B first close and $8.1 million in converting outstanding notes funds the company’s ...
Ardent Health Services today announced the appointments of Anika Gardenhire, RN, BSN, MMCI, as chief digital information officer and Joe DeSchryver as president of Ardent’s Americas Region. “We are excited to welcome ...
Believes Nymox Management and Board Must Be Held Accountable for Prolonged Underperformance and Egregious Governance Practices Urges Shareholders to Vote on the WHITE Proxy Card to Install New Leadership and a New Board at Upcoming Special MeetingCARS...
Amwell®, a leader in hybrid healthcare enablement, together with Leidos, a FORTUNE® 500 science and technology leader, was recently awarded a next-generation contract to provide a hybrid care technology platform designed to power the “Digital First” transformation of the Military Health System (MHS).
Altera Digital Health, a global health IT leader, today announced that dbMotion™ Solution earned the No. 1 ranking on Black Book Research’s list of the top clinical data integration and interoperability solutions.
Cabinet Health launched its refillable mail-order prescription solution. Cabinet Health Rx is a direct-to-consumer healthcare service dedicated to improving the pharmacy patient experience and the environmental impact of the pharmaceutical industry.
Determining whether a person is diabetic could be as easy as having them speak a few sentences into their smartphone, according to a groundbreaking study from Klick Labs that combines voice technology with artificial intelligence in a major step forward in diabetes detection.
CIONIC, the pioneering neurotech company that created the FDA-cleared Cionic Neural Sleeve, today announced an additional $12 million extension of its Series A financing, bringing the Series A total to $25 million.
Evident Vascular, Inc., a medical technology startup developing a next-generation intravascular ultrasound (IVUS) platform leveraging artificial intelligence to enable superior imaging and streamlined workflows, announced today that it has launched with a $35 million Series A financing from Vensana Capital®.